Sarasin & Partners LLP Zoetis Inc. Transaction History
Sarasin & Partners LLP
- $10.2 Billion
- Q1 2024
A detailed history of Sarasin & Partners LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 348,691 shares of ZTS stock, worth $60.4 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
348,691
Previous 206,195
69.11%
Holding current value
$60.4 Million
Previous $40.7 Million
44.98%
% of portfolio
0.58%
Previous 0.45%
Shares
18 transactions
Others Institutions Holding ZTS
# of Institutions
1,857Shares Held
416MCall Options Held
1.13MPut Options Held
1.81M-
Vanguard Group Inc Valley Forge, PA40.7MShares$7.06 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.7MShares$6.37 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$3.39 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.8 Billion2.46% of portfolio
-
Bank Of America Corp Charlotte, NC14MShares$2.42 Billion0.22% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $81.2B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...